MARKET

CPIX

CPIX

Cumberland Pharmaceuticals Inc
NASDAQ
1.680
0.00
0.00%
Opening 09:30 04/12 EDT
OPEN
--
PREV CLOSE
1.680
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
2.359
52 WEEK LOW
1.430
MARKET CAP
23.82M
P/E (TTM)
-3.8251
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CPIX last week (0401-0405)?
Weekly Report · 4d ago
Weekly Report: what happened at CPIX last week (0325-0329)?
Weekly Report · 04/01 09:11
Cumberland Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
Press release · 03/27 02:02
Weekly Report: what happened at CPIX last week (0318-0322)?
Weekly Report · 03/25 09:11
Weekly Report: what happened at CPIX last week (0311-0315)?
Weekly Report · 03/18 09:11
Cumberland Pharmaceuticals Full Year 2023 Earnings: US$0.44 loss per share (vs US$0.38 loss in FY 2022)
Cumberland Pharmaceuticals shares are down 14% from a week ago. In the last 12 months, the only revenue segment was Specialty Pharmaceutical Products contributing US$39.6m. The largest operating expense was Sales & Marketing costs, amounting to US$18.5m.
Simply Wall St · 03/15 11:16
Weekly Report: what happened at CPIX last week (0304-0308)?
Weekly Report · 03/11 09:11
Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) has US$12.8m of debt. The company uses debt to shore up its balance sheet, but has a positive free cash flow. Debt is a concern for shareholders, but the company does not have a heavy debt load. In the last year Cumberland Pharmaceutical's had a loss before interest and tax of US$5.6m. Despite its debt, the company has a strong balance sheet and has net cash. We are cautious of the company because of its modest revenue growth.
Simply Wall St · 03/07 11:01
More
About CPIX
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever, Kristalose for oral solution, a prescription laxative, for the treatment of constipation, and Omeclamox-Pak, oral, for the treatment of Helicobacter pylori infection and related duodenal ulcer disease. Its brands also include Sancuso transdermal, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia, and Vibativ injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia.

Webull offers Cumberland Pharmaceuticals, Inc. stock information, including NASDAQ: CPIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPIX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CPIX stock methods without spending real money on the virtual paper trading platform.